Prognostic significance of Fc receptor-like 1 in patients with chronic lymphocytic leukemia, hairy cell leukemia, and various B-cell non-Hodgkin's lymphoma
Open Access
- 1 January 2019
- journal article
- Published by Elsevier in Leukemia Research Reports
- Vol. 12, 100181
Abstract
No abstract availableKeywords
Funding Information
- Isfahan University of Medical Sciences (394608)
This publication has 46 references indexed in Scilit:
- Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma – novel and emerging therapiesCancer Management and Research, 2013
- Expression of the Autoimmune Susceptibility Gene FcRL3 on Human Regulatory T Cells Is Associated with Dysfunction and High Levels of Programmed Cell Death-1The Journal of Immunology, 2010
- Fc Receptor-Like 3 Protein Expressed on IL-2 Nonresponsive Subset of Human Regulatory T CellsThe Journal of Immunology, 2009
- FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B‐cell chronic lymphocytic leukemiaEuropean Journal of Immunology, 2008
- FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemiaBlood, 2008
- FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxinsBlood, 2008
- Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCRNucleic Acids Research, 2002
- BXMAS1 Identifies a Cluster of Homologous Genes Differentially Expressed in B CellsBiochemical and Biophysical Research Communications, 2001
- Molecular Cloning and Characterization of SPAP1, an Inhibitory ReceptorBiochemical and Biophysical Research Communications, 2001
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000